Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

2012 Archives

Dec 7, 2012

Philadelphia, PA – December 7, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the renewal of its universal shelf registration statement on Form S-3 was declared...

More
Dec 5, 2012

Philadelphia, PA – December 5, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the Oppenheimer 23nd Annual Healthcare Conference on...

More
Nov 8, 2012

Philadelphia, PA – November 8, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2013 first quarter ended September 30, 2012. For the first...

More
Nov 5, 2012

Philadelphia, PA – November 5, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has made a donation to the American Red Cross to support Hurricane Sandy relief efforts.

More
Nov 2, 2012

Philadelphia, PA – November 2, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2013 first quarter financial results on Thursday,...

More
Sep 14, 2012

Philadelphia, PA – September 14, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...

More
Sep 13, 2012

Philadelphia, PA – September 13, 2012 – Lannett Company, Inc. (NYSE MKT: LCI ) today announced that the company will present at the UBS Global Life Sciences Conference on Wednesday,...

More
Sep 6, 2012

Philadelphia, PA – September 6, 2012 – Lannett Company, Inc. (NYSE MKT: LCI) today reported financial results for the fiscal 2012 fourth quarter and full year ended June 30, 2012. For...

More
Aug 29, 2012

Philadelphia, PA – August 29, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), today announced that the company will release its fiscal 2012 fourth-quarter and full-year financial results...

More
Jul 16, 2012

Philadelphia, PA – July 16, 2012 – Lannett Company, Inc. (NYSE MKT: LCI), a manufacturer of generic pharmaceuticals, today announced that Jeffrey Farber, vice chairman of the board,...

More
May 11, 2012

Philadelphia, PA – May 11, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Paul Taveira to its board of...

More
May 8, 2012

Philadelphia, PA – May 8, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 third quarter and nine months ended March 31, 2012. For the...

More
May 2, 2012

Philadelphia, PA – May 2, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012...

More
Mar 6, 2012

Philadelphia, PA – March 6, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the 24th Annual Roth OC Growth Stock Conference on Monday,...

More
Feb 7, 2012

Philadelphia, PA – February 7, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2012 second quarter and six months ended December 31, 2011....

More
Jan 31, 2012

Philadelphia, PA – January 31, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...

More
Jan 30, 2012

Philadelphia, PA – January 30, 2012 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012...

More
Jan 4, 2012

Philadelphia, PA – January 4, 2012 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special...

More
 

print email rss
Lannett Investor Relations
Lannett Company Products